NCT02466087View on ClinicalTrials.gov

Role of Magnesium Supplementation in the Treatment of Depression

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

December 31, 2016

Conditions
Depression
Interventions
DRUG

Mg Cl

Four supplements a day for 6 weeks.

Trial Locations (1)

05401

University of Vermont, Burlington

All Listed Sponsors
lead

University of Vermont

OTHER

NCT02466087 - Role of Magnesium Supplementation in the Treatment of Depression | Biotech Hunter | Biotech Hunter